Neuraxial Labor Analgesia and Offspring Neurodevelopment
Impact of Maternal Neuraxial Labor Analgesia on Offspring Neurodevelopment. A Multicenter, Prospective, Longitudinal Cohort Study
1 other identifier
observational
4,645
1 country
2
Brief Summary
How perinatal factors affect the long-term development of children has always been an issue of much concern. This study is designed to explore the potential impact of maternal neuraxial labor analgesia exposure on offspring neurodevelopment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2021
CompletedFirst Posted
Study publicly available on registry
July 16, 2021
CompletedStudy Start
First participant enrolled
October 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
June 9, 2026
June 1, 2026
4.1 years
July 6, 2021
June 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of neurodevelopmental delay in offspring at 24 months of age
Neurodevelopment will be assessed using the Ages \& Stages Questionnaires® in Chinese, 3rd edition (ASQ®-3 Chinese; suitable for children from 1 month to 60 months of age). The ASQ®-3 Chinese contains 30 items representing five developmental domains: communication, gross motor, fine motor, problem solving, and personal-social behavior. For each domain, a score that is more than 2 standard deviations below the mean indicates suspected neurodevelopmental delay. A score below the threshold in any of the 5 domains indicates suspected neurodevelopmental delay.
At 24 months of age
Secondary Outcomes (2)
Prevalence of neurodevelopmental delay in offspring at 6 and 12 months of age
At 6 and 12 months of age
Prevalence of maternal depressive symptoms
At 42 days, 6 months, 12 months, and 24 months after childbirth
Study Arms (2)
Neuraxial analgesia exposure
For mothers who accept neuraxial labor analgesia, epidural analgesia or combined spinal-epidural analgesia will be provided according to routine practice of each study center.
No neuraxial analgesia exposure
For patients who do not accept neuraxial labor analgesia, analgesics will be prescribed by obstetricians according to routine practice.
Interventions
Epidural or combined spinal-epidural labor analgesia will be performed according to the routine practice of each study center.
Neuraxial analgesia will not be performed. Analgesics will be prescribed by the obstetricians according to routine practice.
Eligibility Criteria
Primiparae between 18 and 35 years of age with term single cephalic pregnancy who undergo regular prenatal examination in the study centers and are preparing to deliver vaginally.
You may qualify if:
- Primiparae between 18 and 35 years of age with term single cephalic pregnancy;
- Undergo regular prenatal examination in the study centers;
- Preparing to deliver vaginally.
You may not qualify if:
- History of psychiatric diseases (indicate those that are diagnosed before or during pregnancy by psychiatrists);
- History of diseases involving the hypothalamic-pituitary-adrenal axis;
- Presence of contraindications to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy.
- Presence of contraindications to vaginal delivery;
- Other reasons that are considered unsuitable for study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dong-Xin Wanglead
- Shenzhen Maternity & Child Healthcare Hospitalcollaborator
Study Sites (2)
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Shenzhen Maternity and Child Healthcare Hospital
Shenzhen, Guangdong, 518100, China
Related Publications (6)
Liu ZH, He ST, Deng CM, Ding T, Xu MJ, Wang L, Li XY, Wang DX. Neuraxial labour analgesia is associated with a reduced risk of maternal depression at 2 years after childbirth: A multicentre, prospective, longitudinal study. Eur J Anaesthesiol. 2019 Oct;36(10):745-754. doi: 10.1097/EJA.0000000000001058.
PMID: 31356375BACKGROUNDWong CA. Advances in labor analgesia. Int J Womens Health. 2010 Aug 9;1:139-54. doi: 10.2147/ijwh.s4553.
PMID: 21072284BACKGROUNDMorton S, Kua J, Mullington CJ. Epidural analgesia, intrapartum hyperthermia, and neonatal brain injury: a systematic review and meta-analysis. Br J Anaesth. 2021 Feb;126(2):500-515. doi: 10.1016/j.bja.2020.09.046. Epub 2020 Nov 18.
PMID: 33218673BACKGROUNDFlick RP, Lee K, Hofer RE, Beinborn CW, Hambel EM, Klein MK, Gunn PW, Wilder RT, Katusic SK, Schroeder DR, Warner DO, Sprung J. Neuraxial labor analgesia for vaginal delivery and its effects on childhood learning disabilities. Anesth Analg. 2011 Jun;112(6):1424-31. doi: 10.1213/ANE.0b013e3181f2ecdd. Epub 2010 Aug 24.
PMID: 20736436BACKGROUNDWall-Wieler E, Bateman BT, Hanlon-Dearman A, Roos LL, Butwick AJ. Association of Epidural Labor Analgesia With Offspring Risk of Autism Spectrum Disorders. JAMA Pediatr. 2021 Jul 1;175(7):698-705. doi: 10.1001/jamapediatrics.2021.0376.
PMID: 33871547BACKGROUNDWei M, Bian X, Squires J, Yao G, Wang X, Xie H, Song W, Lu J, Zhu C, Yue H, Zhu G, Wang Q, Xu R, Wan C, Sun S, Chen J. [Studies of the norm and psychometrical properties of the ages and stages questionnaires, third edition, with a Chinese national sample]. Zhonghua Er Ke Za Zhi. 2015 Dec;53(12):913-8. Chinese.
PMID: 26887546BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dong-Xin Wang, MD,PHD
Peking University First Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 24 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor and Chairman, Department of Anesthesiology and Critical Care Medicine
Study Record Dates
First Submitted
July 6, 2021
First Posted
July 16, 2021
Study Start
October 14, 2022
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2028
Last Updated
June 9, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share